Peter Seubert

1.8k total citations
9 papers, 451 citations indexed

About

Peter Seubert is a scholar working on Physiology, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, Peter Seubert has authored 9 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 3 papers in Psychiatry and Mental health and 2 papers in Infectious Diseases. Recurrent topics in Peter Seubert's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Peter Seubert is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Peter Seubert collaborates with scholars based in United States and Finland. Peter Seubert's co-authors include Dale Schenk, Robin Barbour, Dora Games, Lei Chang, F. Coria, Barney E. Miller, Carmen Vigo‐Pelfrey, Ivan Lieberburg, Charles H. Blomquist and Ruth Motter and has published in prestigious journals such as Journal of Neuroscience, Neurology and Biological Psychiatry.

In The Last Decade

Peter Seubert

9 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Seubert United States	6	374	194	137	99	71	9	451
Tadafumi C. Ikezu United States	6	246 0.7×	66 0.3×	147 1.1×	120 1.2×	45 0.6×	6	453
Yasuko Komatsuzaki Japan	8	243 0.6×	86 0.4×	167 1.2×	69 0.7×	123 1.7×	12	428
Tapan K. Khan United States	9	201 0.5×	80 0.4×	156 1.1×	66 0.7×	16 0.2×	12	429
Marie‐Emmanuelle Riviere Switzerland	8	278 0.7×	139 0.7×	100 0.7×	88 0.9×	19 0.3×	23	499
Yukifusa Igeta Japan	9	245 0.7×	131 0.7×	149 1.1×	101 1.0×	57 0.8×	19	376
Manuel Maler Germany	5	322 0.9×	125 0.6×	210 1.5×	62 0.6×	43 0.6×	7	433
Dawn Cutler United Kingdom	5	331 0.9×	280 1.4×	89 0.6×	85 0.9×	34 0.5×	8	508
Myles Mullan United States	9	102 0.3×	165 0.9×	130 0.9×	78 0.8×	31 0.4×	9	375
Anette Mörtberg Sweden	9	372 1.0×	163 0.8×	177 1.3×	58 0.6×	57 0.8×	19	698
Randolph D. Andrews United States	10	230 0.6×	125 0.6×	99 0.7×	40 0.4×	79 1.1×	20	479

Countries citing papers authored by Peter Seubert

Since Specialization

Citations

This map shows the geographic impact of Peter Seubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Seubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Seubert more than expected).

Fields of papers citing papers by Peter Seubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Seubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Seubert. The network helps show where Peter Seubert may publish in the future.

Co-authorship network of co-authors of Peter Seubert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Seubert. A scholar is included among the top collaborators of Peter Seubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Seubert. Peter Seubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Schroeter, Sally, Karen Khan, Robin Barbour, et al.. (2008). Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice. Journal of Neuroscience. 28(27). 6787–6793. 102 indexed citations

2.

Seubert, Peter, Michael H. Lee, Frédérique Bard, et al.. (2004). P4-401 Characterization of the humoral response to AN1792 immunization in AD patients. Neurobiology of Aging. 25. S588–S588. 1 indexed citations

3.

Schenk, Dale, Dora Games, & Peter Seubert. (2001). Potential Treatment Opportunities for Alzheimer's Disease Through Inhibition of Secretases and Aβ Immunization. Journal of Molecular Neuroscience. 17(2). 259–267. 31 indexed citations

4.

Schenk, Dale B., Frédérique Bard, Robin Barbour, et al.. (2000). A possible vaccine for treatment of Alzheimer's disease. Neurobiology of Aging. 21. 134–134. 1 indexed citations

5.

Sunderland, Trey, Benjamin Wolozin, Douglas Galasko, et al.. (1999). Longitudinal stability of CSF tau levels in Alzheimer patients. Biological Psychiatry. 46(6). 750–755. 82 indexed citations

6.

Lasser, Robert, Ruth Dukoff, James Levy, et al.. (1998). Apolipoprotein E ?4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease. International Journal of Geriatric Psychiatry. 13(11). 767–774. 14 indexed citations

7.

Ellis, Ronald J., Peter Seubert, Ruth Motter, et al.. (1998). Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. Neuroscience Letters. 254(1). 1–4. 32 indexed citations

8.

Schenk, Dale, Ruth Motter, Dora Kholodenko, Ivan Lieberburg, & Peter Seubert. (1996). 2 Aβ42 and Tau as Markers of Alzheimer's Disease. Neurobiology of Aging. 17(4). S1–S1. 3 indexed citations

9.

Vigo‐Pelfrey, Carmen, Peter Seubert, Robin Barbour, et al.. (1995). Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 45(4). 788–793. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact